邯郸怀孕一个多月不想要怎么办邯郸玛利亚妇产医院看乳腺好吗,邯郸月经有血块吃什么食物,邯郸阴唇两侧有小疙瘩是怎么回事,邯郸治疗慢性宫颈炎,邯郸怀孕早期需要做什么检查,邯郸玛丽亚妇科医院评价,马丽亚医院做月子好么

MOSCOW, Sept. 13 (Xinhua) -- Russian federal space agency -- Roscosmos -- has announced that it would launch four more spacecraft in the forthcoming four months, including two Soyus manned spacecraft to the International Space Station (ISS).In accordance with the work schedule of Roscosmos, two cargo spaceships -- of the "Progress" type -- will be launched on Oct.30, 2011 and on Jan.26, 2012, while the two manned spacecraft will be blast off on Nov.12 and Dec.20.Roscosmos said on Tuesday it had been conducting consultations with NASA over updated plans of the upcoming expeditions to the ISS.According to Roscosmos, the new launch schedule has been drafted on the basis of an investigation into an abortive launch of a cargo spaceship on Aug. 24, when the Progress M-12M cargo spaceship failed to reach the orbit due to a rocket malfunction. Russia announced on the same day to delay its future launches of manned spaceship to ISS.After the retirement of the U.S. space shuttle fleet, Russia's Soyuz spacecraft has become the only way for astronauts to reach the ISS until at least the middle of this decade.

GENEVA, Aug. 19 (Xinhua) -- The World Health Organization (WHO) and the UN Children's Fund (UNICEF) started an emergency vaccination campaign in all accessible areas of South and Central Somalia, WTO spokesperson Tarek Jasarevic said here on Friday.In July 2011 alone, 1,019 suspected measles cases and 31 related deaths were reported in South and Central Somalia, representing 20 percent of all reported cases for this year.The major factors for a measles outbreak in Somalia are low coverage, malnutrition, population movements, and overcrowed internally displaced (IDP) camps."WHO fears that the measles outbreak could affect a high number of people, especially among the vulnerable IDPs whose overall health is already fragile," Jasarevic said.About 2.5 million children aged between 6 and 15 in 10 regions of South and Central Somalia, including children in Mogadishu, will be targeted during this campaign.

LOS ANGELES, July 18 (Xinhua) -- At least 70 genetic mutations may be involved in the formation of colon cancer, far more than scientists previously thought, a new study suggests.The study by researchers at University of Texas (UT) Southwestern Medical Center contradicts previous thinking that only a few mutated genes may play a role in the development of colon cancer."The ways we've been treating patients up to now is to just go after one target when we should be going after three to four different pathways simultaneously," said Dr. Jerry W. Shay, vice chairman and professor of cell biology at UT Southwestern.The new study identified 65 candidate genes and at least five passenger genes whose mutations play significant roles in cancer development. Inactivating the function of any of these tumor- suppressing genes led to a key step in cancer development called anchorage-independent growth, meaning cells piled up on top of each other rather than aligning neatly.According to previous studies, there were 151 candidate genes and that mutations in just eight to 15 of them would lead to cancer. There were 700 other genes classified as passenger genes whose mutations were incidental to cancer growth.Current cancer treatments target just one or two known cancer- driver genes. While patients may get transient tumor burden reduction, almost universally tumor growth returns."Those numbers are dead wrong," Dr. Shay said, suggesting a new approach to colon cancer treatments targeting multiple genes and pathways simultaneously.The next step is further research to classify more accurately which genes drive cancer and which are merely passengers, the researchers said.Study findings were published in the July 2011 Cancer Research (Priority Reports).

WASHINGTON, July 15 (Xinhua) -- Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols -- a natural antioxidant -- may help prevent the development or delay the progression of Alzheimer's disease.The research, led by Giulio Pasinetti, was published online Friday in the Journal of Alzheimer's Disease, which causes brain changes that gradually get worse.This is the first study to evaluate the ability of grape- derived polyphenols to prevent the generation of a specific form of amyloid (A) peptide, a substance in the brain long known to cause the neurotoxicity associated with Alzheimer's disease.In partnership with a team at the University of Minnesota, Pasinetti and collaborators administered grape seed polyphenolic extracts to mice genetically determined to develop memory deficits and A neurotoxins similar to those found in Alzheimer's disease. They found that the brain content of the A*56, a specific form of A previously implicated in the promotion of Alzheimer's disease memory loss, was substantially reduced after treatment.Previous studies suggest that increased consumption of grape- derived polyphenols, whose content, for example, is very high in red wine, may protect against cognitive decline in Alzheimer's. This new finding corroborates those theories."Since naturally occurring polyphenols are also generally commercially available as nutritional supplements and have negligible adverse events even after prolonged periods of treatment, this new finding holds significant promise as a preventive method or treatment, and is being tested in translational studies in Alzheimer's disease patients," said Pasinetti.In Alzheimer's disease, brain cells degenerate and die, causing a steady decline in memory and mental function.

New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world. Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."